Holen Sie sich die Stockscreener-App
4.20
3.45%
0.14
Handel nachbörslich:
4.10
-0.10
-2.38%
Schlusskurs vom Vortag:
$4.06
Offen:
$4.2
24-Stunden-Volumen:
368.63K
Relative Volume:
2.26
Marktkapitalisierung:
$64.99M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-5.98M
KGV:
-11.66
EPS:
-0.3603
Netto-Cashflow:
$-9.83M
1W Leistung:
+8.81%
1M Leistung:
+16.34%
6M Leistung:
+33.33%
1J Leistung:
+83.41%
1-Tages-Spanne:
$4.04
$4.46
1-Wochen-Bereich:
$3.76
$4.65
52-Wochen-Spanne:
$1.75
$4.65
Grace Therapeutics Inc Stock (GRCE) Company Profile
Firmenname
Grace Therapeutics Inc
Sektor
Branche
Telefon
609-322-1602
Adresse
103 CARNEGIE CENTER, PRINCETON
Compare GRCE vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
4.20 | 62.82M | 0 | -5.98M | -9.83M | -0.3603 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-02 | Eingeleitet | TD Cowen | Buy |
| 2020-09-01 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-07-06 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-01-13 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2019-08-29 | Eingeleitet | B. Riley FBR | Buy |
| 2019-07-18 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Grace Therapeutics Inc Aktie (GRCE) Neueste Nachrichten
Market Trends: Is KIMPRN a play on infrastructure spending2026 WrapUp & Fast Entry High Yield Tips - baoquankhu1.vn
Traumatic Brain Injury Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Neuren Pharma, NeuroVive Pharma, Stemedica Cell Techn, Grace Lab - Barchart.com
Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Update - MarketBeat
Is Grace Therapeutics Inc. stock positioned for digital transformation2025 Trade Ideas & AI Forecasted Entry and Exit Points - Naître et grandir
Aug Selloffs: What is the cash position of Willis Lease Finance Corporation2025 Short Interest & Technical Confirmation Alerts - baoquankhu1.vn
Aug Patterns: Will Haoxin Holdings Limited stock outperform Nasdaq indexTrend Reversal & Weekly Watchlist for Hot Stocks - Naître et grandir
Moderna | History, Innovation, Challenges, & Facts | Britannica Money - Britannica
Aug Momentum: Is now the right time to enter SAIA2025 AllTime Highs & Low Risk High Win Rate Picks - baoquankhu1.vn
GRCE SEC FilingsGrace Therapeutics, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
GRCE: IV nimodipine shows superior efficacy and compliance over oral forms for aSAH treatment - TradingView
Institution Moves: What is Grace Therapeutics Incs valuation compared to sector2025 Trade Ideas & Safe Entry Zone Tips - baoquankhu1.vn
Is OXLC.G forming a breakout patternPortfolio Performance Report & Free Daily Entry Point Trade Alerts - mfd.ru
Rate Hike: Can Grace Therapeutics Inc weather a recessionProfit Target & Reliable Price Action Trade Plans - baoquankhu1.vn
ANTX PE Ratio & Valuation, Is ANTX Overvalued - Intellectia AI
PYPD PE Ratio & Valuation, Is PYPD Overvalued - Intellectia AI
GRCE Should I Buy - Intellectia AI
Buy Signal: Is MSAI forming a breakout pattern2025 Trading Volume Trends & Expert Approved Momentum Ideas - baoquankhu1.vn
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - Bitget
Grace CEO joins TD Cowen event with IV nimodipine program - Stock Titan
The 9 Best Robinhood Penny Stocks in March 2026 - The Stock Dork
Stop Loss: Does CRVS stock benefit from AI growthWeekly Trade Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
NVIDIA Corporation (NVDA) to Supply Standalone Grace CPUs in Landmark Data Center Rollout - Yahoo Finance
Companies Like Grace Therapeutics (NASDAQ:GRCE) Are In A Position To Invest In Growth - Sahm
ADAR1 discloses 9.9% Grace Therapeutics (GRCE) ownership in 13G/A - Stock Titan
Aug PreEarnings: Is Grace Therapeutics Inc a turnaround storyMarket Risk Report & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
SAPMY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Can MetaVia Inc. stock outperform in a bear marketTreasury Yields & Proven Capital Preservation Methods - mfd.ru
Will Grace Therapeutics Inc. stock sustain high P E ratios2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
Does Grace Therapeutics Inc. have a sustainable dividend2025 Volume Leaders & Real-Time Volume Surge Alerts - mfd.ru
Is EVGOW stock a top momentum playPortfolio Update Report & Daily Entry Point Alerts - mfd.ru
Is SFYX stock good for wealth creation2025 Price Momentum & Real-Time Volume Analysis - mfd.ru
GRCE PE Ratio & Valuation, Is GRCE Overvalued - Intellectia AI
BOL.ST Should I Buy - Intellectia AI
Analysts Are Bullish on Top Healthcare Stocks: Grace Therapeutics (GRCE), Alto Neuroscience, Inc. (ANRO) - The Globe and Mail
Is Grace Therapeutics Inc. still a buy after recent gainsWeekly Trading Summary & Technical Pattern Alert System - mfd.ru
Amy C. Moore and Roland Matthews: When Professional Excellence Meets Personal Grace - Oncodaily
Grace Therapeutics announces third quarter 2026 financial results, provides business update - marketscreener.com
Grace Therapeutics (NASDAQ:GRCE) Announces Earnings Results - MarketBeat
Grace Therapeutics (GRCE) Advances Towards FDA Review with Promi - GuruFocus
Is Grace Therapeutics Inc. a cyclical or defensive stockWeekly Stock Summary & Accurate Trade Setup Notifications - mfd.ru
Grace: Fiscal Third Quarter Earnings Overview - Bitget
Grace: Fiscal Q3 Earnings Snapshot - kare11.com
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update - The Manila Times
Grace Therapeutics Q3 2026 Financial Results and Business Update - TradingView
April 23 FDA target date set for Grace’s GTx-104 aSAH drug - Stock Titan
Grace Therapeutics, Inc. SEC 10-Q Report - TradingView
Why is Grace Therapeutics Inc. stock going upShort Setup & Verified Trade Idea Suggestions - mfd.ru
Jobs Data: Can Grace Therapeutics Inc weather a recession2025 Sector Review & Expert-Curated Trade Recommendations - baoquankhu1.vn
Aug Selloffs: What are the risks of holding BioXcel Therapeutics Inc.Weekly Volume Report & Consistent Growth Stock Picks - mfd.ru
Grace Therapeutics (GRCE) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Volatility Watch: Can SolarBank Corporation generate free cash flowJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Finanzdaten der Grace Therapeutics Inc-Aktie (GRCE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):